研究论文

1. Baohong Li; Zhongyuan Li; Ying Tan; Beibei Yan; Wenting Ni; Yiming Yin; Q. Cui; Qingjun Zhu ; Latex Derived fromFicus caricaL. Inhibited the Growth of NSCLC by Regulating the Caspase/Gasdermin/AKT Signaling Pathway, Food & Function, 2023, 14(4): 2239-2248

2. Su F, Yang G, Hu D, Ruan C, Wang J, Zhang Y, Zhu Q. Chemical Composition, Antibacterial and Antioxidant Activities of Essential Oil fromCentipeda minima. Molecules. 2023 Jan 13;28(2):824.

3. Xu M, Cui Q, Su W, Zhang D, Pan J, Liu X, Pang Z, Zhu Q. High-content screening of active components of Traditional Chinese Medicine inhibiting TGF-β-induced cell EMT.Heliyon.2022;8(8):e10238.

4. Wang D, Gong L, Li Z, Chen H, Xu M, Rong R, Zhang Y, Zhu Q. Antifibrotic effect of Gancao Ganjiang decoction is mediated by PD-1 / TGF-β1 / IL-17A pathway in bleomycin-induced idiopathic pulmonary fibrosis. J Ethnopharmacol.2021;281:114522.

5. Pang Z, Lin TJ. Mice with double knockout of Egr-1 and RCAN1 exhibit reduced inflammation during Pseudomonas aeruginosa lung infection. Immunobiology. 2023;228(3):152377.

6. Pang Z, Zhu Q. Traditional Chinese Medicine is an Alternative Therapeutic Option for Treatment of Pseudomonas aeruginosa Infections. Front Pharmacol;2021,12: 737252.

7. Pang, Z, Gu, MD, and Tang, T. Pseudomonas aeruginosa in Cancer Therapy: Current Knowledge, Challenges and Future Perspectives. Front Oncol.2022;12:891187.

8. Pang, Z., Xu, Y., Zhu, Q. Early Growth Response 1 Suppresses Macrophage Phagocytosis by Inhibiting NRF2 Activation Through Upregulation of Autophagy During Pseudomonas aeruginosa Infection. Front Cell Infect Microbiol.2021;11: 773665.

9. Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z.Antibiotic resistance in Pseudomonas aeruginosa: mechanisms andalternative therapeutic strategies. Biotechnol Adv 2019, 37:177-92.

10. Pang Z, Raudonis R, McCormick C, Cheng Z. Early growth response 1 deficiency protects host against Pseudomonasaeruginosa lung infection.Infect Immun 2019, 88.

11. Pang Z*, Junkins RD*, MacNeil AJ, McCormick C, Cheng Z, Chen WM, Lin TJ. The calcineurin-NFAT axis contributes tohost defense during Pseudomonas aeruginosa lung infection. J Leukoc Biol 2017, 102:1461-9.

12. Pang Z, Junkins RD, Raudonis R, MacNeil AJ, McCormick C, Cheng Z, Lin TJ: Regulator of calcineurin 1differentiallyregulates TLR-dependent MyD88 and TRIF signaling pathways. PLoS One 2018, 13:e0197491.

13.张成华,崔清华,田景振,王萍,侯林,公腾,张丹,朱庆均.金贝口服液对博来霉素诱导的大鼠肺纤维化的作用研究.中药药理与临床,2018,34(06):146-150.

14. Pang Z, Sun G, Junkins RD, Lin TJ. AIM2 inflammasome is dispensable for the host defense against Pseudomonasaeruginosa infection. Cell Mol Biol (Noisy-le-grand) 2015, 61:63-70.

15. Zhu Q, Liu C, Ge Z, Fang X, Zhang X, Strååt K, Björkholm M, Xu D. Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene. PLoS One. 2008 Jan 16;3(1):e1446.

发明专利：

1.发明专利名称：罗勒多糖提取物在制备治疗肺纤维化药物中的应用；专利号：ZL 201710043225.9；授权日期：2020年2月7日；专利权人：山东中医药大学，发明人：朱庆均，张丹，肖丽，侯林，张颖颖，闫丹丹，张成华，李雅群

2.发明专利名称:金银花石油醚部位提取物在制备治疗肺纤维化药物中的应用；CN201711235428.4；授权日期：2021年3月2日；专利权人：山东中医药大学，发明人：容蓉，朱庆均，李雅群，王旭，张成华，王萍

3.发明专利名称：罗勒多糖用作抗肿瘤化疗药增效剂在制备抗肿瘤药物中的应用，授权号：ZL 2014 1 0569118.6，授权日期：2017年3月8日，专利权人：山东中医药大学，发明人：朱庆均，肖丽，张丹，李路，于华静